RxSight Inc. (RXST) PT Raised to $75 at Stifel

Go back to RxSight Inc. (RXST) PT Raised to $75 at Stifel

RxSight Inc. (RXST) PT Raised to $68 at Wells Fargo

May 7, 2024 5:53 AM EDT

Wells Fargo analyst Lawrence Biegelsen raised the price target on RxSight Inc. (NASDAQ: RXST) to $68.00 (from $61.00) while maintaining a Overweight rating.

The analyst comments "We raise our 2024 EPS estimate from -$1.02 to -$0.86. Our price target increases to $68 (from $61) based on 13x (from 11x... More

RxSight Inc. (RXST) PT Raised to $72 at BTIG

May 7, 2024 5:19 AM EDT

BTIG analyst Ryan Zimmerman raised the price target on RxSight Inc. (NASDAQ: RXST) to $72.00 (from $61.00) while maintaining a Buy rating.

The analyst comments "We reiterate our Buy and raise our PT to $72 PT (from $61) following 1Q24 results. RXST delivered a strong start to FY24 with 1Q24 revenue of $29.5M (69% Y/Y) and adj. LPS of $(0.25)... More

RxSight Inc. (RXST) PT Raised to $70 at Morgan Stanley

May 6, 2024 11:42 PM EDT

Morgan Stanley analyst Patrick Wood raised the price target on RxSight Inc. (NASDAQ: RXST) to $70.00 (from $65.00) while maintaining a Overweight rating.... More

RxSight, Inc. (RXST) Tops Q1 EPS by 17c

May 6, 2024 4:17 PM EDT

RxSight, Inc. (NASDAQ: RXST) reported Q1 EPS of ($0.12), $0.17 better than the analyst estimate of ($0.29). Revenue for the quarter came in at $29.5 million versus the consensus estimate of $27.56 million.

For earnings history and earnings-related data on RxSight, Inc. (RXST) click here.

... More

RxSight Inc. (RXST) PT Raised to $68 at Stifel

May 6, 2024 5:59 AM EDT

Stifel analyst Tom Stephan raised the price target on RxSight Inc. (NASDAQ: RXST) to $68.00 (from $64.00) while maintaining a Buy rating.... More